Table 1 Demography and baseline characteristics of study subjects
Characteristics | Value |
|---|---|
Gender(male/female) | 11/12 |
Age of onset, y | 50.4 ± 8.5 |
Duration, y | 11.3 ± 5.8 |
Age of surgery, y | 61.7 ± 8.3 |
H&Y stage (off-med) | |
Mild(<3) | 9 (39.1%) |
Severe(≥3) | 14 (60.9%) |
Levodopa responsiveness, % | 62.5 ± 19.3 |
LEDD, mg/d | 999.3 ± 516.7 |
Dyskinesia | |
No | 14 (60.9%) |
Yes | 9 (39.1%) |
Motor fluctuations duration, y | 5.4 ± 3.9 |
Disease subtype | |
LPS | 12(52.2%) |
PIGD | 11 (47.8%) |
Baseline UPDRSIII scores (off-med) | 50.2 ± 18.2 |